DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Yao X, Abraham NS, Sangaralingham LR. , et al.
Effectiveness and safety of Dabigatran, Rivaroxaban, and Apixaban versus Warfarin in nonvalvular atrial fibrillation.
J Am Heart Assoc 2016;
5 (06) e003725
We do not assume any responsibility for the contents of the web pages of other providers.